Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

3(37.5%)

Phase 2

2(25.0%)

Phase 1

2(25.0%)

Early Phase 1

1(12.5%)

8Total

N/A(3)

Phase 2(2)

Phase 1(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07436793Phase 2Not Yet Recruiting

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

Role: collaborator

NCT06934642Early Phase 1Recruiting

Effect of Tirzepatide on Markers of MASLD in Patients With Obesity

Role: collaborator

NCT04251299Not ApplicableCompleted

Southwest Harvest for Health Vegetable Gardening Intervention

Role: collaborator

NCT04321694Unknown

Expanded Access for KHK2455

Role: collaborator

NCT05176743Not ApplicableCompleted

Food Insecurity in Oncology

Role: collaborator

NCT00846612Phase 1Completed

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Role: collaborator

NCT00462865Phase 2Terminated

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Role: collaborator

NCT03632694Not ApplicableCompleted

The Move for Your Health Pilot Study

Role: collaborator

NCT01607554Phase 1Terminated

Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer

Role: collaborator

All 9 trials loaded